Operator: Good day, ladies and gentlemen, and welcome to Repligen’s 2023 Third Quarter Earnings Conference Call. My name is Keith, and I will be your coordinator.
Life sciences company Repligen Corp. (RGEN) announced Tuesday third-quarter net income of $18.17 million or $0.32 per share, sharply down from $40.41 million or $0.
By Ben Glickman Shares of Repligen Corp. rose after the company logged an unexpected profit in the third quarter. The stock was up 19% to $135.64 in Tuesday.
RBC Capital Reiterates Repligen (RGEN) Outperform Recommendation nasdaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nasdaq.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The life science and chemical instrumentation market size is expected to grow by USD 14.94 billion from 2021 to 2026. In addition, the momentum.